Metraipolis › archive › dc_c2c3a2f4e5d6

Carrier cross-reactivities of the bile acid reabsorption inhibitors elobixibat, linerixibat, maralixibat, and odevixibat — Europe PMC PMID:40998033

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40998033
DOI
10.1016/j.jlr.2025.100910
License (as archived)
solo-consultazione
Archived
2026-11-09T19:26:50.442Z
SHA-256 of the archived text
b5db32fb2abac33a378db55e1dd8f3c9569b85644e71f16fc9117fbca96f386f
Stable URL of this page
https://metraipolis.com/documento/dc_c2c3a2f4e5d6

How to cite

Carrier cross-reactivities of the bile acid reabsorption inhibitors elobixibat, linerixibat, maralixibat, and odevixibat — Europe PMC PMID:40998033 — Europe PMC (en), https://europepmc.org/article/MED/40998033 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c2c3a2f4e5d6 (Metraipolis archive dc_c2c3a2f4e5d6, sha256 b5db32fb2abac33a378db55e1dd8f3c9569b85644e71f16fc9117fbca96f386f)
BibTeX
@misc{dcc2c3a2f4e5d6,
  title = {Carrier cross-reactivities of the bile acid reabsorption inhibitors elobixibat, linerixibat, maralixibat, and odevixibat — Europe PMC PMID:40998033},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40998033},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c2c3a2f4e5d6; sha256 b5db32fb2abac33a378db55e1dd8f3c9569b85644e71f16fc9117fbca96f386f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40998033. Agents can read the archived copy with the MCP tool read_document.